+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Epidermolysis bullosa: novel and de novo premature termination codon and deletion mutations in the plectin gene predict late-onset muscular dystrophy



Epidermolysis bullosa: novel and de novo premature termination codon and deletion mutations in the plectin gene predict late-onset muscular dystrophy



Journal of Investigative Dermatology 114(2): 381-387



Epidermolysis bullosa (EB) with late-onset muscular dystrophy (EB-MD) is a hemidesmosomal variant of EB due to mutations in the plectin gene (PLEC1). The age of onset of muscle involvement has been noted to vary from infancy to the fourth decade of life. Immunofluorescence of the patients' skin and muscle biopsies is usually negative for staining with antibodies recognizing plectin, a large cytoskeleton-associated anchorage protein. In this study we report novel plectin mutations in two families with EB. In both families, the proband was a newborn with neonatal blistering with no evidence for muscle weakness as yet. Peripheral blood DNA was isolated and examined by heteroduplex scanning strategy, protein truncation test (PTT), and/or direct sequencing of the plectin gene. One of the probands was compound heterozygote for nonsense mutations E2005X/K4460X, and the proband in the second family was compound heterozygote for deletion mutations 5083delG/2745-9del21, the latter mutation extending from -9 to +12 at the intron 22/exon 23 border. The mutations K4460X and 5083delG were not present in either one of the parents, thus being de novo events. In both cases, nonpaternity was excluded by microsatellite marker analysis. The stop codon mutations are predicted to result in the synthesis of a truncated protein lacking the carboxy-terminal globular domain of the protein and possibly causing nonsense-mediated decay of the corresponding mRNA. The 2745-9del21 deletion mutation abolishes the splice site at the intron 22/exon 23 junction, predicting abnormal splicing events. Because plectin deficiency is associated with muscular dystrophy, molecular diagnostics of the plectin gene provides prognostic value in evaluation of these patients who appear to be at risk to develop muscular dystrophy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010598575

Download citation: RISBibTeXText

PMID: 10652002

DOI: 10.1046/j.1523-1747.2000.00880.x


Related references

Epidermolysis bullosa with muscular dystrophy A novel premature termination codon and de novo deletion mutations in the plectin gene. Journal of Investigative Dermatology 112(4): 615, 1999

Novel compound heterozygous mutations in the plectin gene in epidermolysis bullosa with muscular dystrophy and the use of protein truncation test for detection of premature termination codon mutations. Laboratory Investigation; a Journal of Technical Methods and Pathology 78(2): 195-204, 1998

Novel compound heterozygous mutations in the plectin gene in epidermolysis bullosa with muscular dystrophy , and development of protein truncation test for detection of premature termination codon mutations. Journal of Investigative Dermatology 108(4): 562, 1997

Homozygous deletion mutations in the plectin gene (PLEC1) in patients with epidermolysis bullosa simplex associated with late-onset muscular dystrophy. Human Molecular Genetics 5(10): 1539-1546, 1996

Epidermolysis bullosa with late-onset muscular dystrophy and plectin deficiency. Muscle and Nerve 44(1): 135-141, 2011

Epidermolysis bullosa simplex with muscular dystrophy Cloning of the human plectin gene and pathogenic mutations in four families. American Journal of Human Genetics 59(4 Suppl. ): A38, 1996

Congenital muscular dystrophy, myasthenic symptoms and epidermolysis bullosa simplex (EBS) associated with mutations in the PLEC1 gene encoding plectin. Neuromuscular Disorders 20(11): 709-711, 2010

Recurrent COL7A1 mutations in Japanese patients with dystrophic epidermolysis bullosa: positional effects of premature termination codon mutations on clinical severity. Japanese Collaborative Study Group on Epidermolysis Bullosa. Journal of Investigative Dermatology 112(6): 991-993, 1999

Four novel plectin gene mutations in Japanese patients with epidermolysis bullosa with muscular dystrophy disclosed by heteroduplex scanning and protein truncation tests. Journal of Investigative Dermatology 112(1): 109-112, 1999

Novel premature termination codon mutations in the laminin gamma2-chain gene in herlitz junctional epidermolysis bullosa. Journal of Investigative Dermatology 111(6): 1233-1234, 1998

Downstream effects of plectin mutations in epidermolysis bullosa simplex with muscular dystrophy. Acta Neuropathologica Communications 4(1): 44, 2016

Novel premature termination codon mutations in the laminin gamma2-chain gene (LAMC2) in Herlitz junctional epidermolysis bullosa. Journal of Investigative Dermatology 111(6): 1233-1234, 1998

Premature termination codon mutations in the type VII collagen gene (COL7A1) underlie severe recessive dystrophic epidermolysis bullosa. Proceedings of the Association of American Physicians 107(2): 245-252, 1995

Premature termination codon mutations in the type VII collagen gene in recessive dystrophic epidermolysis bullosa result in nonsense-mediated mRNA decay and absence of functional protein. Journal of Investigative Dermatology 109(3): 390-394, 1997